Procter & Gamble Agrees to Discontinue Claim That Gain Ultra Dish Soap Has “30% More Degreasers vs. Ajax” Following Challenge By Colgate-Palmolive.

New York, NY – Feb. 25, 2019 – The Procter & Gamble Company has agreed to discontinue its claim that its Gain Ultra Dish Soap has “30% More Degreasers vs. Ajax” following a challenge by Colgate-Palmolive Company before the National Advertising Division.

NAD is an investigative unit of the advertising industry’s system of self-regulation and is administered by the Council of Better Business Bureaus.

Colgate-Palmolive contended that the claim that Gain Ultra Dish Soap has “30% more degreasers vs. Ajax,” made on product packaging and the advertiser’s website, necessarily communicates the message that the product has 30% more cleaning power than its product—a claim that, it argued, is unsupported.

During the pendency of this NAD proceeding, the advertiser informed NAD in writing that the claim “30% More Degreasers vs. Ajax” is being permanently discontinued and that bottles bearing new labels without the challenged claim were already being disseminated in the marketplace.

Based on the advertiser’s assertion in writing that it has permanently discontinued the challenged claim, NAD did not review the “30% More Degreasers vs. Ajax” claim on its merits. The voluntarily discontinued claim will be treated, for compliance purposes, as though NAD recommended their discontinuance and the advertiser agreed to comply.

In its advertiser’s statement, The Procter & Gamble Company stated that it remains a strong supporter of the industry self-regulation process, thanked NAD for its time and attention to this matter, and stated that it agrees to comply with NAD’s recommendations.

Note: A recommendation by NAD to modify or discontinue a claim is not a finding of wrongdoing and an advertiser’s voluntary discontinuance or modification of claims should not be construed as an admission of impropriety. It is the policy of NAD not to endorse any company, product, or service. Decisions finding that advertising claims have been substantiated should not be construed as endorsements.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

Direct Selling Self-Regulatory Council Recommends Valentus Discontinue Earnings and Product Performance Claims

McLean, VA – December 23, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended Valentus, a direct selling company that sells nutritional and lifestyle products, discontinue earnings and health-related product performance claims made on social media and on the Valentus website.

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Refers Olive Tree Earnings Claims to the FTC and California AG for Possible Enforcement Action

McLean, VA – December 20, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) referred Olive Tree to the Federal Trade Commission (FTC) and California Attorney General's Office for possible enforcement action after Olive Tree failed to respond to a DSSRC inquiry into earnings claims.  

Read the Decision Summary
Decision

Children’s Advertising Review Unit Recommends JustPlay Discontinue or Modify Daisy the Yoga Goat Claims

New York, NY – December 19, 2024 - The Children’s Advertising Review Unit (CARU) launched an investigation into advertising for Just Play’s furReal Daisy the Yoga Goat seeking to determine if the toy’s product packaging and commercial advertisements comply with CARU’s Self-Regulatory Guidelines for Children’s Advertising.

Read the Decision Summary
Decision

In National Advertising Division Fast-Track SWIFT Challenge, Oral Essentials Voluntarily Modifies “Made in USA” Claims

New York, NY – December 19, 2024 – In a National Advertising Division challenge, Oral Essentials agreed to permanently modify its claim that certain Oral Essentials oral healthcare products are “Made in USA.” 

Read the Decision Summary